Financhill
Sell
20

CTXR Quote, Financials, Valuation and Earnings

Last price:
$0.84
Seasonality move :
23.69%
Day range:
$0.80 - $0.86
52-week range:
$0.63 - $5.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.26x
Volume:
1.3M
Avg. volume:
1.3M
1-year change:
-74.6%
Market cap:
$17.5M
Revenue:
--
EPS (TTM):
-$3.81

Earnings Data

Next earnings date for CTXR
Feb 12
2026
Most recent earnings per share
-$0.44
Missed by $0.20
(Dec 23/2025)
Consensus Estimate
-$0.24
(Dec 23/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CTXR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/12/2026 Q4 $3.5M -- -- -- --
12/23/2025 Q3 -- -- -$0.44 -$0.24 -$0.20
08/12/2025 Q2 $1.9M -- -$0.80 -$0.21 -$0.59
05/13/2025 Q1 -- -- -$1.27 $0.11 -$1.38
02/14/2025 Q4 -- -- -$1.30 -$1.25 -$0.05
12/27/2024 Q3 -- -- -$1.59 -$1.50 -$0.09
08/12/2024 Q2 -- -- -$1.57 -$1.13 -$0.44
05/14/2024 Q1 -- -- -$1.34 -$1.50 $0.16
02/14/2024 Q4 -- -- -$1.45 -- --
09/30/2023 Q3 -- -- -$1.75 -$1.50 -$0.25
08/14/2023 Q2 -- -- -$1.38 -- --
05/12/2023 Q1 -- -- -$1.80 -- --
02/10/2023 Q4 -- -- -$0.61 -- --
09/30/2022 Q3 -- -- -$1.37 -- --
08/11/2022 Q2 -- -- -$1.52 -- --
05/12/2022 Q1 -- -- -$1.29 -- --
02/10/2022 Q4 -- -- -$1.58 -- --
12/16/2021 Q3 -- -- -$0.85 -- --
08/12/2021 Q2 -- -- -$1.33 -- --
05/13/2021 Q1 -- -- -$1.07 -- --
02/11/2021 Q4 -- -- -$3.66 -- --
12/16/2020 Q3 -- -- -$1.85 -- --
08/14/2020 Q2 -- -- -$2.81 -- --
05/14/2020 Q1 -- -- -$3.22 -- --
12/31/2019 Q4 -- -- -$3.70 -- --
09/30/2019 Q3 -- -- -$4.00 -- --
06/30/2019 Q2 -- -- -$5.01 -- --
03/31/2019 Q1 -- -- -$4.91 -- --
12/31/2018 Q4 -- -- -$5.45 -- --
09/30/2018 Q3 -- -- -$4.39 -- --
06/30/2018 Q2 -- -- -$4.75 -- --
03/31/2018 Q1 -- -- -$11.00 -- --
12/31/2017 Q4 -- -- -$9.50 -- --
09/30/2017 Q3 -- -- -$11.00 -- --
06/30/2017 Q2 -- -- -$12.25 -- --
03/31/2017 Q1 -- -- -$15.00 -- --
12/31/2016 Q4 -- -- -$11.25 -- --
09/30/2016 Q3 -- -- -$13.28 -- --
06/30/2016 Q2 -- -- -$18.75 -- --
03/31/2016 Q1 -- -- -$7.50 -- --
12/31/2015 Q4 -- -- -$15.00 -- --

Citius Pharmaceuticals, Inc. Earnings Questions

  • How Much did Citius Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Citius Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Citius Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Citius Pharmaceuticals, Inc. announced earnings per share of -$0.44 which represents a miss of analyst forecast a -$0.24 per share.

  • Is Citius Pharmaceuticals, Inc. Profitable?

    Citius Pharmaceuticals, Inc. reported -$62K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Citius Pharmaceuticals, Inc. EPS Next Year?

    Citius Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$3.38 per share to $1.90 per share next year representing a decrease of -65.18%.

  • When is Citius Pharmaceuticals, Inc.'s Earnings Date?

    Citius Pharmaceuticals, Inc.'s next earnings date is February 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock